International   |   Contact   |   Home
 

Heart Failure Clinics
Heart Failure
Acoustic Cardiography
Data Sheet (PDF)
CME Supplement
Case Studies
FAQs
Reimbursement
Clinical Trials
User Guides
Ordering Information
Product Support
Publications
Continuing Education

Hospital   |   EMS

Contact Us:
Inovise Medical, Inc.
Phone: (503) 431-3800

 

HF Clinic Products

DISCOVER AUDICORŪ TS

As a busy cardiologist caring for patients in your practice, you and your staff are on the leading edge of helping to diagnose and manage many of the 500,000 new heart failure cases identified each year. As you have experienced, cardiac resynchronization therapy (CRT) has emerged as an effective therapy option for NYHA class III or IV patients.

About 25% of heart failure patients also suffer from left ventricular (LV) mechanical dyssynchrony. The integrated function of all heart chambers are key determinants of heart failure. Nonuniformities of mechanical contraction, or dyssynchrony can lead to inefficient pump performance and energy expenditure in cardiac patients. Consequently, these patients experience suboptimal ventricular filling, a reduction in LV dP/dt (rate of rise of ventricular contractile force or pressure), prolonged duration of mitral regurgitation, and paradoxical septal wall motion. Ventricular dyssynchrony has also been associated with increased mortality in HF.

Acoustic cardiography offers a new innovative method of helping assess dyssynchrony and hemodynamic measures. Click here to learn more about how acoustic cardiography can help clinicians manage their heart failure patients.

 

Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.  Am Heart J 2002;143:398-405.

Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289:730-40.

 

Top

 
  Terms of Use | Site Map